Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5000 participants.
Also called NCT03278509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 5,000 participants
- Registry
-
NCT03278509
-
- Other papers using this trial's data
- Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- Psychometric properties of the Swedish cardiac anxiety questionnaire: a Rasch analysis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Unknown status
Technical summary
Registry record NCT03278509. Randomized; no masking; primary purpose treatment. Start 2017-09-11 (actual); primary completion 2023-11-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
- Condition
- Acute Myocardial Infarction
- Condition
- Non-ST Elevation Myocardial Infarction
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- Metoprolol Succinate
- Intervention (Drug)
- Bisoprolol
- Lead sponsor
- Karolinska Institutet
- Collaborator
- Uppsala University
- Collaborator
- The Swedish Research Council
Record details
- Record id
cardio:ct-nct03278509- Content hash
40b44660011d9f717d246dd1c99d53f42e4c9b5bdc170dddb7205464d3860c5a